Key facts
- 4D Medicine’s last known valuation is $17.8M (Dec 2025).
- It has raised $6.5M; the latest was Later Stage VC ($4.0M) in Dec 2025.
- Notable investors include Innovate UK, SFC Capital, Mercia Ventures, Mercia Asset Management, Midlands Engine Investment Fund — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for 4D Medicine
- ·The full record, as it builds
Funding rounds
No funding rounds for 4D Medicine are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About 4D Medicine
Manufacturer of degradable, implantable medical devices made from novel photopolymer materials. The company is taking a range of devices through regulatory clearance with the FDA(Food and Drug Administration)) before commercial launch, helping medical device suppliers provide patients with resorbable medical devices that help optimize outcomes in applications such as musculoskeletal surgery, soft tissue repair, and drug delivery.
- Sector
- Materials and Resources
- HQ
- Nottingham, United Kingdom
- Founded
- 2018
- Employees
- 11
- Website
- 4dmedicine.co.uk/
- Ownership
- Privately Held (backing)
4D Medicine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in 4D Medicine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on 4D Medicine in its N-PORT filings yet. We sweep new filings monthly.